• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Additive Manufacturing (AM)

Additive Manufacturing (AM)

AM showcases the latest technology and industry developments with in-depth case studies, resources, interviews with experts and events.

    • CHANNEL
      • Aerospace
      • Automotive
      • Energy
      • Medical
      • Innovation
    • TOPICS
      • Design
      • Management
      • Materials
      • Post Processing
      • Processes
      • Quality Management Systems
      • Regulatory & Standards
      • Software
      • Workforce Development
    • NEWS
    • EVENTS
      • Conferences
      • Virtual Events
      • Webinars
      • Industry Events
      • On-Demand
      • Add Your Event
    • MEDIA
      • AM News LIVE
      • AM Voices
      • Podcast
      • Video
    • RESOURCES

    Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis

    Triastek received FDA clearance to initiate clinical studies of the 3D printed medicine, T21, potential treatment for ulcerative colitis.

    NANJING, China, Nov. 21, 2022 — Triastek, Inc., a healthcare company pioneering 3D printing of pharmaceuticals with its proprietary technology, Melt Extrusion Deposition (MED®), announced it received clearance for its Investigational New Drug (IND) application from the United States Food and Drug Administration (FDA) to initiate clinical studies of the 3D printed medicine, T21, a potential treatment for ulcerative colitis.

    “We are excited to receive IND clearance to begin clinical trials of this potentially transformative treatment for patients, ” said Dr. Senping Cheng, founder and CEO of Triastek. “Delaying drug release and delivering oral dosage forms to the colon is challenging, so T21 offers a promising new option for patients by providing site-specific drug delivery and localized drug effect, mitigating potential side effects from systemic exposure. We look forward to advancing this treatment into the clinic and appreciate the FDA’s support. “

    T21 is a novel potential treatment capable of colon-targeted drug delivery. With a unique 3D dosage form design, T21 can reach the targeted colon segment of the GI tract, thus permitting use of a lower drug dose than the reference listed drug, which provides systemic exposure. Made possible by 3D printing, radio-imaging agents embedded in specific components of the dosage form were employed in early formulation development to evaluate and confirm the location of drug release in the GI tract. This novel process can be utilized in the development of future drugs targeted to specific segments of the GI tract to increase the efficiency and success rate of product development. The delayed-release, colon-targeted oral tablet technology platform can not only be used for developing small molecule drugs, but for peptide drugs as well.

    Triastek had already received IND clearance from the FDA for its T19 and T20 products for treatment of rheumatoid arthritis and cardiovascular and clotting disorders, respectively. Triastek continues to demonstrate the broad applicability of its MED® technology through the advancement of products that solve a wide range of drug delivery challenges across multiple therapeutic areas.

    related /

  • Triastek Receives FDA IND Clearance for 3D Printed Product of Blockbuster Molecule
  • nkos Surgical has received 510(k) clearance for patient-specific Pelvic Reconstruction system with 3D printed implants, instruments, and models. Onkos Surgical Receives FDA 510(k) Clearance for 3D Printed, Patient-Specific Pelvic Reconstruction System
  • RICOH 3D for Healthcare has received 510(k) clearance from the FDA for its craniomaxillofacial and orthopedic patient-specific anatomic modeling. Ricoh’s Anatomic Modeling Receives FDA Clearance
  • Filed Under: News

    Primary Sidebar

    events /

    upcoming webinars /

    • There are no upcoming events.

    on demand /

    • SOLIDWORKS Certification Tips and Tricks

      January 24 @ 11:00 am - 12:00 pm EST
    • Is there really a use for additive manufacturing in commercial vehicles?

      December 7, 2022 @ 1:00 pm - 2:00 pm EST
    • Development of Metal Additive Manufacturing for Naval Shipbuilding

      December 1, 2022 @ 1:00 pm - 2:00 pm EST

    Footer

    AM-logo_RGB_500_white

    With dozens of innovative products, materials, software, and applications being launched constantly, you can rely on AdditiveManufacturing.com to keep you ahead of the curve.

    stay connected /

    recent /

    • Research & Development: AM News Roundup for January 23-February 3, 2023
    • TrabTech Announces Seed Investment for Serialization of CE-Certified 3D Printed Implants and Research Fund of 1.3 Million Euros for Development of 3D Printable Smart Biomaterials
    • Desktop Metal Announces Update on Cost Reduction Plans for 2023 to Accelerate Path to Profitability
    • Uniformity Labs Launches UniFuse™ AlSi10Mg Aluminum Powder for Laser Powder Bed Fusion (L-PBF)
    • polySpectra Launches World’s Most Rugged Resin for Desktop 3D Printers
    • Dimension Inx Raises $12M Series A to Accelerate Commercialization of New Generation of Regenerative Therapeutics
    • C3Nano Announces Industry’s First Highly Conductive, Low Temperature Curing, Flexible and Stable Printable Ink Solution
    • BCIT and Teck Open Teck Copper Innovation Hub

    topics /

    • Applications
    • Design
    • Materials
    • Post Processing
    • Processes
    • Quality Management Systems
    • Regulatory & Standards
    • Software

    media /

    • Watch On-Demand: AM News LIVE: EP22 – Anne Pauley & Michael Molitch-Hou – CES, TIPE, AMS – Monday, January 23rd 2023
    • AM Materials Chat: 6K onsite at Formnext 2022 – AM Voices Podcast – Frank Roberts, President of 6K Additive
    • Watch On-Demand: AM News LIVE: EP21 – Sintavia – Brian R. Neff – Monday, January 9th 2023
    • Formnext 2022 flashback: Uniformity Labs, CEO Adam Hopkins on LPBF materials for 3D printing
    • AM Materials Chat: Uniformity Labs onsite at Incodema3D – AM Voices video podcast – Adam Hopkins, CEO at Uniformity Labs
    • AM Materials Chat: Elementum3D onsite at Incodema3D for AM Voices video podcast
    • AM Video Interview: Dr. Jason Rolland, SVP of Materials at Carbon
    • Watch On-Demand: AM News LIVE, EP20 – End Of Year Episode – 2022 Review with Friends

    Copyright © 2023 Metrix Connect, LLC

    • Advertise
    • About Us
    • Privacy Policy
    • Terms of Use
    • Editorial Guidelines
    • Code of Conduct
    • Contact